Larimar Therapeutics, Inc.·4

Feb 15, 4:21 PM ET

THOMAS FRANK E 4

4 · Larimar Therapeutics, Inc. · Filed Feb 15, 2024

Insider Transaction Report

Form 4
Period: 2024-02-14
Transactions
  • Purchase

    Common Stock

    2024-02-14$11.00/sh+2,000$22,0002,000 total

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES